Tammela
Antti Tammela, Vtt FI
Patent application number | Description | Published |
---|---|---|
20140059067 | EXCHANGE OF INFORMATION - The invention relates to a method for exchange of information between a computing unit of a first entity and a computing unit of at least one second entity. A computing unit of at least one second entity is detected and information on a token associated to the second entity from the computing unit is requested and received. On the basis of the received information, the token associated to the at least one second entity, is retrieved and a token associated to the first entity is modified at least partly with information of the received token associated to the at least one second entity. Finally, the modified token is utilized at least in the service the computing unit of the first entity belongs to. The invention relates also to a system and a computing unit implementing the method. | 02-27-2014 |
Päivi Tammela, Helsinki FI
Patent application number | Description | Published |
---|---|---|
20100196290 | COMPOSITIONS COMPRISING BETULONIC ACID - The invention relates to compositions of cosmetic and pharmaceutical industries comprising betulonic acid for humans and animals, and further, to the use of betulonic acid in compositions of cosmetic and pharmaceutical industries. The invention is also directed to compositions containing, besides betulonic acid, optionally other compounds derived from betulin. | 08-05-2010 |
20100273801 | BETULIN DERIVED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS - The invention relates to compouns derived from betulin, and to the use thereof as antibacterial agents in pharmaceutical and cosmetic applications. | 10-28-2010 |
Päivi Tammela, Helsinki FI
Patent application number | Description | Published |
---|---|---|
20100196290 | COMPOSITIONS COMPRISING BETULONIC ACID - The invention relates to compositions of cosmetic and pharmaceutical industries comprising betulonic acid for humans and animals, and further, to the use of betulonic acid in compositions of cosmetic and pharmaceutical industries. The invention is also directed to compositions containing, besides betulonic acid, optionally other compounds derived from betulin. | 08-05-2010 |
20100273801 | BETULIN DERIVED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS - The invention relates to compouns derived from betulin, and to the use thereof as antibacterial agents in pharmaceutical and cosmetic applications. | 10-28-2010 |
Simo Tammela, Espoo FI
Patent application number | Description | Published |
---|---|---|
20100220965 | OPTICAL FIBER STRUCTURE AND A METHOD OF PRODUCING THEREOF - An optical waveguide including a core, a buffer surrounding the core, and a cladding surrounding the buffer. The core, the buffer and the cladding include silica glass. A refractive index of the buffer is substantially equal to a refractive index of pure amorphous silica glass. The buffer may reduce bubble formation during manufacturing and may facilitate splicing of the waveguide. A numerical aperture of the waveguide may be fine-tuned by adjusting a radial dimension of the buffer in order to compensate variations in the refractive index of the core. | 09-02-2010 |
Simo Tammela, Vantaa FI
Patent application number | Description | Published |
---|---|---|
20160123581 | BURNER NOZZLE, BURNER AND A SURFACE TREATMENT DEVICE - A burner nozzle is disclosed, comprising a nozzle body that includes a slit such that a line passage to the slit opens in an outlet face surface at the surface of the burner nozzle body. A plurality of channels is connected to the slit. A group of first channels is connected to a source of oxidizing substance, and a group of second channels is connected to a fuel source. Each of the first channels and second channels have a circumferential passage to the slit at a non-zero distance from the outlet face surface. Furthermore, each of the first channels and second channels is formed to output a directed tubular flow towards a side wall of the slit, or towards a circumferential passage in a side wall of the slit. A safe pre-mixed burner configuration is achieved. A burner and a surface treatment device incorporating the burner nozzle are also disclosed. | 05-05-2016 |
Tuomas Tammela, Helsinki FI
Patent application number | Description | Published |
---|---|---|
20080267924 | AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERY - The present invention provides materials and methods for repairing tissue and using vascular endothelial growth factor C (VEGF-C) genes and/or proteins. Methods and materials related to the use of VEGF-C for the reduction of edema and improvement of skin perfusion is provided. Also provided is are materials and methods for using VEGF-C before, during, and after reconstructive surgery. | 10-30-2008 |
20100041605 | Use of VEGF-C or VEGF-D in Reconstructive Surgery - The present invention provides materials and methods for repairing tissue and using vascular endothelial growth factor C (VEGF-C) genes and/or proteins. Methods and materials related to the use of VEGF-C for the reduction of edema and improvement of skin perfusion is provided. Also provided is are materials and methods for using VEGF-C before, during, and after reconstructive surgery. | 02-18-2010 |
20120071406 | MODIFIED VEGF-A WITH IMPROVED ANGIOGENIC PROPERTIES - The present invention is directed to methods and compositions for making and using chimeric polypeptides that comprise a VEGFR-2 ligand. The chimeric molecules of the present invention retain VEGFR-2 binding activity and an enhanced angiogenic activity as compared to native VEGF-A. | 03-22-2012 |
20120125348 | AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERY - The present invention provides materials and methods for repairing tissue and using vascular endothelial growth factor C (VEGF-C) genes and/or proteins. Methods and materials related to the use of VEGF-C for the reduction of edema and improvement of skin perfusion is provided. Also provided is are materials and methods for using VEGF-C before, during, and after reconstructive surgery. | 05-24-2012 |
20120141424 | Materials and Methods for the Treatment of Hypertension - The present invention is directed to materials and methods for the treatment of hypertension and ischemia comprising administering at least one therapeutic agent selected from the group consisting of vascular endothelial growth factor-C product and vascular endothelial growth factor-D product, and optionally, when treating hypertension, a standard of care anti-hypertensive agent. | 06-07-2012 |